This year, chemical industry accidents occurred frequently. It was reported that on the afternoon of April 15, Qilu Tian and Hui Shi Pharmaceutical Co., Ltd. in the basement of the freeze-dried vehicle in the process of pipeline reconstruction, the low-temperature heat transfer medium was ignited by the electric welding spark, which generated smoke and caused on-site operation. Eight of the 10 staff members died on the spot and the remaining two staff members died during the rescue. Another 12 rescue workers were injured and were not in danger. Tested by the environmental protection department, it has no impact on the surrounding environment. The accident is under further investigation and disposal.
There have been at least 5 accidents in the history of the plant.
The data shows that this is not the first explosion of the plant.
In October 2016, a recycling tank was found in the wastewater recycling workshop of Qilu Pharmaceutical Factory. At that time, no casualties were caused, and two workers were administratively detained. However, an explosion caused a sensation among the teachers, students and parents of the next school. Afterwards, many parents asked the drug factory to relocate. Finally, the official ended with Qilu Pharmaceutical’s decision to suspend production and rectify and relocate Licheng No. 2 Middle School.
According to the Qilu Evening News report, in the two years of 2015 and 2016, there have been three accidents in the factory. One of them occurred two months before the "10.10" explosion in 2016. At that time, a fire broke out in a production workshop of the factory. The fire area was about 20 square meters, causing no casualties. The pharmaceutical factory was ordered to rectify.
Going back, in January 2011, there was a fire in Qilu Pharmaceutical. At that time, a constant temperature library for storing animal vaccines and other drugs in the factory was on fire. The smoke that emerged lasted for more than ten hours.
In addition to this accident, Tianhe Huishi Pharmaceutical Factory has had at least 5 accidents. Only the previous accidents did not cause any casualties, and the accident had the greatest impact.
On Tianhe's official website, the company has won more than ten honors in recent years, but there are no award-winning projects on environmental protection.
The company involved is a subsidiary of the pharmaceutical company
According to the company's data, Tianhe Hui Shi is a subsidiary of Shandong Pharmaceutical Leading Qilu Pharmaceutical. It was established on December 7, 2006 with a registered capital of more than 600 million yuan. The legal representative is Li Baoyong and the actual controller is Li Yan. 26.8%. Its bigshareholderIt is Shandong Qilu Pharmaceutical Group Co., Ltd., which holds 60% of the shares, and the other shareholder is Ante Hong Kong International Co., Ltd., which accounts for 40%.
According to Qilu Pharmaceutical's official website, Tianhe Huishi integrates raw materials and pharmaceutical production, scientific research, pharmaceutical R&D outsourcing and other businesses into one. It has been ranked among the top 100 comprehensive strengths of the national chemical and pharmaceutical industry for many years, with an accumulated investment of more than RMB 1 billion. .
Its products cover anti-infective, anti-tumor, cardiovascular, neurological, neurological and nervous systems. The plant has an anti-tumor chemical synthesis production base, an amikacin production workshop and a tazobactam production workshop, and a large freeze-drying area. A sterile freeze-dried workshop group.
The explosion was in the basement of the freeze-drying workshop. The official website shows that there are nearly ten kinds of products stored in the factory. The sterile raw material is tazobactam sodium, and the non-sterile raw materials include tazobactam, amikacin, amikacin sulfate, alprazolam, and card. MoFl, hydroxyurea, tegafur, etc., as well as the preparation of Bangda.
Among them, Bangda preparations are stably exported to Japan, Europe, Australia and other countries. Tianhe Hui Shi is the only domestic injection of injection products to Japan, and its partners include international pharmaceutical giants such as Pfizer and Novartis. The damage caused by the explosion to the inventory of the company's workshop is still unclear.
The impact of the explosion on the industry
Before, the “321” explosion accident in Xiangshui, Jiangsu Province triggered a shock in the chemical industry. On April 1, Jiangsu Province issued a draft opinion on the “Jiangsu Province Chemical Industry Improvement and Improvement Plan”. On April 4th, Yancheng decided to completely shut down the Xiangshui Chemical Industry Park. The opinion draft clearly stated: First, a comprehensive evaluation of 50 chemical parks in the province should be carried out. According to the evaluation results, it should be reduced to about 20; secondly, by the end of 2020, the number of chemical enterprises in the province will be reduced to 2,000. By 2022, there will be no more than 1,000 chemical companies in the province.BrokerAnalysts believe that from a policy perspective, environmental protection will continue to be in a high-pressure situation, and industry reshuffle will continue.
Tianfeng Securitiesresearch reportIt is pointed out that raw material medicine has the same periodic nature as the chemical industry. Under the background of strict environmental protection, the threshold for the production of APIs has increased, and the small factories have gradually cleared up, and the competition pattern has stabilized.
Qilu Pharmaceutical's official website shows that Tianhe Hui Shi has formed a complete industrial chain from raw materials to finished products. The company has an advanced Amika production workshop and a tazobactam production workshop.
Earlier media reports said that Tianhe Hui Shi is the largest producer of tazobactam in China with an annual production capacity of 80 tons. According to the official website of the Leling City Environmental Protection Bureau, Qilu Tian and Hui Shi (Leling) Pharmaceutical Co., Ltd. will build a 200-ton/year tazobactam production line in 2017, and the production capacity of tazobactam will increase 2.5 times.
For the bombing incident, a market person who has long been concerned about the pharmaceutical industry told the company's reporter that Qilu Pharmaceutical is an important raw material drug manufacturer. It is foreseeable that the accident will inevitably set off a certain range of environmental protection and rectification. The degree will increase, the price of raw materials will rise, and even out of stock, the supply is in short supply, and listed companies with the same variety are expected to benefit.
(Article source: Securities Times Network)